Compound Detail
CHEMBL5176275
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL5176275 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | YARRHMNCZKMKNX-UHFFFAOYSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
468.6
MW (Da)
5.44
ALogP
7
HBA
0
HBD
62.3
PSA (Ų)
0.33
QED
1
Ro5 Violations
13
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 1 meas. best 5.08
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| SARS-CoV-2 CHEMBL4303835 | EC50 | 5.08 | 5.08 | 8300.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| SARS-CoV-2 | EC50 | = | 8300.0 | nM | 5.08 | Antiviral activity against SARS-CoV-2 infected in eGFP expressing African green ... | 35571875 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 35571875 | 10.1021/acsmedchemlett.2c00123 | SARS-CoV-2 | 1 |
| 35571875 | 10.1021/acsmedchemlett.2c00123 | Vero C1008 | 1 |
| 35571875 | 10.1021/acsmedchemlett.2c00123 | ADMET | 1 |
Data from ChEMBL 36 via Core Engine